Five facility certificates published
Certification Assurance International issued Lyotek Labs five facility certificates on 27 October 2026, and all of them are now published on this site as the issuer's PDFs.
News from the laboratory
Announcements from Lyotek: new compounds and presentations, certifications, the laboratory itself and where our distributor supplies the vials.
Lyotek research peptides now reach more than 170 countries
Through its exclusive distributor, Lyotek research peptides now reach laboratories in more than 170 countries from the laboratory in Switzerland.
Our exclusive distributor expands to the Middle East, Southeast Asia and Latin America
Lyotek's exclusive distributor has extended its coverage to three new regions, which brings local support to laboratories there.
Growth hormone axis range opens with Tesamorelin, CJC-1295 and Ipamorelin
Three research peptides open a new section of the Lyotek catalogue: Tesamorelin at 20 mg, and CJC-1295 and Ipamorelin at 10 mg each.
Retatrutide joins the catalogue in 20 mg and 40 mg vials
Lyotek adds retatrutide to its metabolic research range, in two presentations of the same 3 ml vial.
KLOW and GLOW Stack, two research blends in a single vial
Lyotek introduces its first two blends, each lyophilised together in one 3 ml vial: KLOW at 80 mg and GLOW Stack at 70 mg.
Lyotek expands its laboratory in Switzerland
A second freeze-drying suite and a larger analytical laboratory are now in operation at the Lyotek laboratory.
